Ethosomes as non-invasive loom for transdermal drug delivery system

Nanomedicine and Drug Delivery

Volumn 1, Issue , 2012, Pages 1-16

  Sudhakar, C K ^a   Upadhyay, Nitish ^a   Jain, Sanjay ^a   Charyulu, R Narayana ^b  

^a Smriti College of Pharmaceutical Education   (India)

^b NITTE DEEMED TO BE UNIVERSITY   (India)

Author keywords

Cannabidiol; Dermatopharmacotherapy; Ethosomes; Methotrexate; Scanning electron microscopy; Stratum corneum; Trihexyphenidyl

Indexed keywords

EID: 84899084466     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (78)

1. Barry, B.W. (2001). Novel Mechanism and devices to enable successful transdermal drug delivery. European J. Pharm. Sci. 14(2), 101-114.
2. Bendas, E.R. and Tadros, M.I. (2007). Enhanced Transdermal Delivery of Salbutamol Sulfate via Ethosomes. AAPS PharmSciTech.14 8(4), E107.
3. Bhalaria, M.K., Naik, S., and Mishra, A.N. (2009). Ethosomes: A novel system for antifungal drugs in the treatment of topical fungal disease. Ind. J. Exp. Bio. 47, 368-375.
4. Bouwstra, J.A. and Honeywell-Nguyen, P.L. (2002). Skin structure and mode of action of vesicles. Adv. Drug Deliv. Rev. 54 Suppl 1, S41-S55.
5. Bouwstra, J.A., Honeywell-Nguyen, P.L., Gooris, G.S., and Ponec M., (2003). Structure of the skin barrier and its modulation by vesicular formulations. Prog. Lipid Res. 42, 1-36.
6. Byung, S.J., Yong, M.H., Kwang, H.L., and Moon, J.C. (2004). Preparation and characterization of calcein Entrapped ethosome. J. Korean Ind. Eng. Chem. 15(2), 205-210.
7. Cevc, G. (2004). Lipid vesicles and other colloids as drug carriers on the skin. Adv. Drug Deliv. Rev. 56(5), 675-711.
8. Cevc, G. and Blume, G. (1992). Lipid vesicles penetrate into intact skin owing to the transdermal osmotic gradients and hydration force. Biochimica et Biophysica Acta 1104, 226-232.
9. Cevc, G., Blume, G., Schatzlein, A., Gebauer, D., and Paul, A. (1996). The skin: A pathway for systemic treatment with patches and lipid-based agents carriers. Adv. Drug Del. Rev. 18, 349-378.
10. Cevc, G., Blume, G., and Schatzlein, A., (1997). Transfersomes-mediated transepidermal delivery improves the region-specificity and biological activity of corticosteroids in vivo. J. Control. Release 45, 211-226.
11. Chin, J.H. and Goldstein, D.B. (1997). Membrane disordering action of ethanol: Variation with membrane cholesterol content and depth of the spin label probe. Mol. Pharmacol. 13, 435.
12. Choi, M.J. and Maibach, H.J. (2005). Liposomes and Niosomes as topical drud delivery systems. Skin Pharmacol. Physiol. 18, 209-219.
13. Cortesi R., Ravani, L., Zaid A.N., Menegatti, E., Romagnoli, R., Drechsler, M., and Esposito, E. (2010). Ethosomes for the delivery of anti-HSV-1 molecules: Preparation, characterization and in vitro activity. Pharmazie 65(10), 743-749.
14. Daniels, R. (2004). Strategies for skin Penetration Enhancement, Skin care Forum. Cognis 37, 89-96.
15. Dayan, N. and Touitou, E. (2000). Carriers for skin delivery of trihexyphenidyl HCl: Ethosomes vs liposomes. Biomaterials 21(18), 1879-1885.
16. David, C.P. (2001). New drug delivery systems, in Handbook of modern pharmaceutical analysis. S. Ahuja and S. Scypinski (Eds.), vol 3 Separation Science and technology. Academic Press, USA.
17. Dayan. N. and Touitou, E. (2002). Carrier for skin delivery of trihexyphenidyl HCl: Ethosomes vs liposomes. Biomaterials 21, 1879-1885.
18. Deo, M.R., Sant, V.P., Prakash, S.R., Khopade, A.J., and Banakar, U.V. (1997). Proliposomes based transdermal delivery of levonorgestrel. J. Biomaterials Appli. 12, 77-85.
19. Dubey, V., Mishra, D., Dutta, T., Nahar, M., Saraf, D.K., and Jain, N.K. (2007). Dermal and transdermal delivery of an anti-psoriatic agent via ethanolic liposomes. J. Control Release 123, 148-154.
20. El Maghraby, G.M., Williams, A.C., and Barry, B.W. (2001). Skin delivery of 5-fluorouracil from ultradeformable and standard liposomes in vitro. J. Pharm. Pharmacol. 53, 1069-1077.
21. El Maghraby, G.M., Williams, A.C., and Barry, B.W. (2006). Can drug-bearing liposomes penetrate intact skin? J. Pharm. Pharmacol. 58, 415-429.
22. Elsayed, M.M., Abdallah, O.Y., Naggar, V.F., and Khalafallah, N.M. (2006). Deformable liposomes and ethosomes: Mechanism of enhanced skin delivery. Int. J. Pharm. 322, 60-66.
23. Elsayed, M.M., Abdallah, O.Y., Naggar, V.F., and Khalafallah, N.M. (2007). Deformable liposomes and ethosomes as carriers for skin delivery of ketotifen. Pharmazie 62, 133-137.
24. Esposito, E., Menegatti, E., and Cortesi, R. (2004). Ethosomes and liposomes as topical vehicles for azelaic acid: A preformulation study. J. Cosmet. Sci. 55, 253-264.
25. Fang, Y.P., Tsai, Y.H., Wu, P.C., and Huang, Y.B. (2008). Comparison of 5-aminolevulinic acid-encapsulated liposome versus ethosome for skin delivery for photodynamic therapy. Int. J. Pharm. 356, 144-152.
26. Godin, B. and Touitou, E. (2003). Ethosomes: New prospects in transdermal delivery. Crit. Rev. Ther. Drug. Carrier Syst. 20, 63-102.
27. Godin, B. and Touitou, E. (2004). Mechanism of bacitracin permeation enhancement through the skin and cellular membrane from an ethosomal carrier. J. Control. Release 94, 365-379.
28. Godin, B., Touitou, E., Rubinstein, E., Athamna, A., and Athamna, M. (2005a). A new approach for treatment of deep skin infections by an ethosomal antibiotic preparation: An in vivo study. J. Antimicrob Chemother. 55(6), 989-994.
29. Godin, B. and Touitou E. (2005b). Erythromycin ethosomal systems: Physicochemical characterization and enhanced antibacterial activity. Curr. Drug Deliv. 2(3), 269-725.
30. Gupta, P., Singh, P., Mishra, V., and Jain, S. (2004). Topical immunization: Mechanistic insight and novel delivery system. Ind. J. Bio. 3, 9-21.
31. Hadgraft, J. (1996). Recent developments in topical and transdermal delivery. European J. Drug Metab Pharmacokinet 21, 165-173.
32. Hans Schreief and Joke Bouwstrab (1994). Liposomes and niosomes as topical drug carriers: Dermal and transdermal drug delivery. Journal of Controlled Release 30, l-15.
33. Harris, R.A. (1987). Effect of ethanol on membrane order: Fluorescence studies. Ann. N.Y. Acad Sci. 492, 125.
34. He, R., Cui, D.X., and Gao, F. (2009). Preparation of fluorescence ethosomes based on quantum dots and their skin scar penetration properties. Mater. Lett. 63, 1662-1664.
35. Hogaki, K., Ammuaikit, C., and Kimura, T. (2003). Strategies for overcoming the stratum corneum. Am. J. Drug Deliv. 1(3), 187-214.
36. Honeywell-Nguyen, P.L. (2003b). The effect of surfactant-based elastic and rigid vesicles on the penetration of lidocain across human skin. STP Pharma. Sci. 12, 57-262.
37. Honeywell-Nguyen, P.L., De Graff, A.M., Wouter Groenink, H.W., and Bouwstra, J.A. (2002a). The in vivo and in vitro interactions of elastic and rigid vesicles with human skin. Biochim. Biophys. Acta 1573, 130-140.
38. Honeywell-Nguyen, P.L. and Bouwstra, J.A. (2003). The in vitro transport of pergolide from surfactant-based elastic vesicles through human skin: A suggested mechanism of action. J. Control. Release 86, 145-156. http://www.ntt-inc.com/Opportunities/StategicPartnerships/tabid/75/Default.aspx
39. Hyo Jung Gwak and Byung Suk Jin (2007). Preparation and Characterization of EGCG Entrapped Ethosome. J. Korean Ind. Eng. Chem. 18(2), 130-135.
40. Jacobs, M., Martin, G.P., and Marriott, C. (1988). Effects of phosphatidylcholine in the topical bioavailability of corticosteroids assessed by the human skin blanching assay. J. Pharm. Pharmacol. 40, 829-833.
41. Jain, N., Talegankar, S., and Jam, N.K., (2004). New ways to enter the blood stream. Emerging Strategies in Transdermal drug delivery. The Pharma Review:Sep-Oct, 41-66.
42. Jain, S., Bhandra, D., and Jain, N.K. (1997). Transfersome-A novel carrier for effective transdermal drug delivery. Controlled and novel drug delivery 1st edition-CBS publishers and distributors, New Delhi, pp. 426-451.
43. Jain, S., Tiwary, A.K., Sapra, B., and Jain, N.K. (2007). Formulation and evaluation of ethosomes for transdermal delivery of lamivudine. AAPS Pharm. Sci. Tech. 8(4).
44. Jakob, T.M., Stefan, V., Ann-Therese, K., Carl, S., Jeanne, D.J., and Klaus, E. Andersen (2010). Ethosome Formulations of Known Contact Allergens can Increase their Sensitizing Capacity. Acta Derm Venereol. 90, 374-378.
45. John, D. and Mullins (1980). Medicated Application, Remington Pharm Sci. 16th edition, Mack publishing Company Eastern, Pennsylvania. vol 87, 1518-1519.
46. Kikwai, L., Babu, R.J., Prado, R., Kolot, A., Armstrong, C.A., Ansel, J.C., and Singh, M. (2005). In vitro and in vivo Evaluation of Topical Formulations of Spantide II. AAPS Pharm. Sci. Tech. 6(4), 34-39.
47. Kirjavainen, M., Urtti, A., Valjakka-Koskela, R., Kiesvaara, J., and Monkkonen, J. (1999b). Liposome-skin interactions and their effects on the skin permeation of drugs. Eur. J. Pharm. Sci. 7, 279-286.
48. Koli, J.R. and Lin, S. (2009). Development of anti oxidant ethosomes for topical delivery utilizing the synergistic properties of Vit A palmitate, Vit E and Vit C. AAPS Pharm. Sci. Tec. 11, 1-8.
49. Kumar, R. and Katare, O.P. (2005). Lecithin Organogels as a Potential Phospholipid Structured for Topical Drug Delivery. A Review. AAPS Pham. Sci. Tech. 06(02), 56-61.
50. Lasch, J., Laub, R., and Wohlrab, W. (1992). How deep do intact liposomes penetrate into human skin? J. Control. Rel. 18(1), 55-58.
51. Liu, X., Liu, H., Liu, J., He, Z., Ding, C., Huang, G., Zhou, W., and Zhou, L. (2011). Preparation of a ligustrazine ethosome patch and its evaluation in vitro and in vivo. Int. J. Nanomedicine 6, 241-247.
52. Lodzki, M., Godin, B., Rakou, L., Mechoulam, R., Gallily, R., and Touitou, E. (2003). Cannabidiol- transdermal delivery and anti-inflammatory effect in a murine model. J. Control Release 93, 377-387.
53. Lopez-Pinto, J.M., Gonzalez-Rodriguez, M.L., and Rabasco, A.M. (2005). Effect of cholesterol and ethanol on dermal delivery from DPPC liposomes. Int. J. Pharm. 298(1), 1-12.
54. Merdan, V.M., Alhaique, F.E., Touitou, E. (1998). Vesicular carriers for Topical delivery. Acta Technologiae et Legis Medicoment 91, 1-6.
55. Mishra, D., Mishra, P.K., Dubey, V., Nahar, M., and Jain, N.K. (2007). Systemic and mucosal immune response induced by transcutaneous immunization using Hepatitis B surface antigenloaded modified liposomes. J. Control Release 33, 424-433.
56. Paolino, D., Lucania, G., Mardente, D., Alhaique, F., and Fresta, M. (2005). Ethosomes for skin delivery of ammonium glycyrrhizinate: In vitro percutaneous permeation through human skin and in vivo anti-inflammatory activity on human volunteers. J. Control Release 106, 99-110.
57. Ranjit, S. and Vyas, S.P. (1996). Selective drug delivery through and within the skin using liposomes. Indian J. Pharm. Sci. 58(1), 9-17.
58. Rao, Y., Zheng, F., Zhang, X., Gao, J., and Liang, W. (2008). In vitro percutaneous permeation and skin accumulation of finasteride using vesicular ethosomal carriers. AAPS Pharm. Sci. Tech. 9(3), 860-865.
59. Sang, M.L. and Byung, S.J. (2005). Stability of ascorbyl palmitate entrapped in ethosome. Applied Chemistry 9(1), 145-148.
60. Schmid, M.H. and Korting, H.C. (1994). Liposomes: A drug carrier system for topical treatment in dermatology. Crit. Rev. Ther. Drug carrier Syst. 11, 97-118.
61. Shumilov, M., Bercovich, R., Duchi, S., Ainbinder, D., and Touitou, E. (2010). Ibuprofen transdermal ethosomal gel: Characterization and efficiency in animal models. J. Biomed. Nanotechnol. 6(5), 569-576.
62. Singh, H.P., Utreja, P., Tiwary, A.K., and Jain, S. (2008). Elastic liposomal formulations for sustained delivery of Colchicine: In vitro characterization and In vivo evaluation of anti gout activity. AAPS Pharm. Sci. Tec. 11, 54-64.
63. Touitou, E. (1996). Compositions for applying active substances to or through the skin. US Patent 5, 540, 934.
64. Touitou, E. (1998). Composition for applying active substances to or through the skin, US Patent 5, 716, 638.
65. Touitou, E. (2002). Drug delivery across the skin. Expert Opin. Biol. Ther. 2, 723-733.
66. Touitou, E., Alkabes, M., and Dayan, N. (1997). Ethosomes: Novel lipid vesicular system for enhanced delivery. Pharm. Res. S14, 305-306.
67. Touitou, E., Dayan, N., Bergelson, L., Godin, B., and Eliaz, M. (2000a). Ethosomes-novel vesicular carriers for enhanced delivery: Characterization and skin penetration properties. J. Contr. Rel. 65, 403-418.
68. Touitou, E., Godin, B., and Weiss, C. (2000b). Enhanced delivery into and across the skin by ethosomal carries. Drug Dev. Research 50, 406-445.
69. Touitou, E. and Godin, B. (2006). Vesicles for enhanced delivery into and through the skin. In Enhancement in drug delivery. E. Touitou and B.W. Barry (Eds.). CRC Press, Taylor & Francis Group, Boca Raton-London-New York, pp. 255-278.
70. Touitou, E and Godin, B. (2007). Dermal drug delivery with ethosomes: Therapeutic potential. Future Medicine July 4(4), 465-472.
71. Trima Israel Pharmaceutical Products Maabarot Ltd., data on SupraVir cream file.
72. Verma, D.D., Verma, S., Blume, G., and Fahr, A. (2003). Liposomes increase skin penetration of entrapped and non-entrapped hydrophilic substances into human skin: A skin penetration and confocal laser scanning microscopy study. Eur. J. Pharm. Biopharm. 55, 271-277.
73. Vora, B., Khopade, A. J, and Jain, N.K. (1998). Proniosome based transdermal delivery of levonorgestrel for effective contraception. J. Control Release 54, 149-165.
74. William, A.B. (2007). Application of thermal analysis to the study of the dental materials. Handbook of Thermal Analysis and Calorimetry vol 5;.Recent Advances. Techniques and Applications. M.E. Brown and P.K. Gallagher (Eds.). Elsevier, pp. 670-677.
75. Yi-Ping Fang, Yaw-Bin Huang, Pao-Chu Wu, Yi-Hung Tsai (2009). Topical delivery of 5-aminolevulinic acid-encapsulated ethosomes in a hyperproliferative skin animal model using the CLSM technique to evaluate the penetration behaviour. Eur. J. Pharm. Biopharm. 73(3), 391-398.
76. Zhaowu, Z., Xiaoli, W., Yangde, Z., and Nianfeng, L. (2009). Preparation of matrine ethosome, its percutaneous permeation in vitro and anti-inflammatory activity in vivo in rats. J. Liposome Res. 19(2), 155-162.
77. Zhou, Yan, Wei, Yu-Hui, Zhang, Guo-Qiang, Wu, Xin-An (2010). Synergistic penetration of ethosomes and lipophilic prodrug on the transdermal delivery of acyclovir. Archives of Pharmacal Research 33(4), 567-574.
78. Zhu, W.W., Zhai, G.X., and Zhao, J. (2007). Progress on ethosomes. Food and Drug 9(01), 46-49.